TELESTA THERAPEUTICS
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guรฉrin (BCG). Telesta submitted a Biologics Licensing Application... (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
TELESTA THERAPEUTICS
Social Links:
Industry:
Biotechnology Manufacturing Pharmaceutical Therapeutics
Founded:
1979-01-01
Address:
Pointe-claire, Quebec, Canada
Country:
Canada
Website Url:
http://www.telestatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(514) 697-6636
Email Addresses:
[email protected]
Total Funding:
28.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Maps Content Delivery Network LetsEncrypt Amazon SSL By Default ReCAPTCHA Nginx
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Angus Chemical
Angus Chemical specialty and fine chemical company dedicated to the development of novel chemistries.
Animol Discovery
We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Epix Pharmaceuticals
EPIX Pharmaceuticals is a biopharmaceutical company engaging in the discovery and development of therapeutics.
Neuropathix
Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline pain management therapeutics.
Wing Inflatables
A Lafayette, Calif.-based maker of inflatable boats and other inflatable products
Xellia Pharmaceuticals
Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing clinically effective anti-infective treatments against
Current Advisors List
Founder
Investors List
Consonance Capital Partners
Consonance Capital Partners investment in Venture Round - Telesta Therapeutics
Omega Funds
Omega Funds investment in Venture Round - Telesta Therapeutics
Boxer Capital
Boxer Capital investment in Venture Round - Telesta Therapeutics
Official Site Inspections
http://www.telestatherapeutics.com
- Host name: 68.71.54.135
- IP address: 68.71.54.135
- Location: Laval Canada
- Latitude: 45.6171
- Longitude: -73.7488
- Timezone: America/Toronto
- Postal: H7K
More informations about "Telesta Therapeutics"
Telesta Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (514) 697-6636 Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing โฆSee details»
Telesta Therapeutics Inc. - LinkedIn
Telesta Therapeutics Inc. | 216 followers on LinkedIn. Telesta Therapeutics was a biotechnology company focused on the licensing/acquisition and development of transformational โฆSee details»
Telesta Therapeutics Inc. Company Profile | Management and
Www.telestatherapeutics.com . Telesta Therapeutics Inc. Profile and History. Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and โฆSee details»
Bioniche Life Sciences Inc. Rebrands as Telesta Therapeutics
BELLEVILLE, ON, Nov. 24, 2014 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC PNK: BNHLF) Bioniche Life Sciences today announced the accomplishment of another major milestone in โฆSee details»
Telesta Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Telesta Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 2 literature, Drug:Mycobacterium cell wall-DNA Complex(Liminal โฆSee details»
Telesta Therapeutics Inc - Dun & Bradstreet
Company Description: Telesta Therapeutics (formerly Bioniche Life Sciences) is seeking its niche in the development of drugs to treat urology, oncology, and immune system disorders. Its main โฆSee details»
Telesta Therapeutics - Products, Competitors, Financials, โฆ
Telesta is a Montreal-based biotechnology company focused on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases โฆSee details»
Telesta Therapeutics Inc - Company Profile and News
Company profile page for Telesta Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Telesta Therapeutics - PitchBook
Telesta Therapeutics General Information Description. Operator of a late-stage biopharmaceutical company in Canada.The company is engaged in the development, manufacturing, โฆSee details»
Telesta Therapeutics Closes US$28.6 Million Private Placement
Aug 19, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) announced today that it has closed a private placement financing of US$28.6 million. This...See details»
Telesta Therapeutics Inc. | Insights
Jul 18, 2016 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Telesta Therapeutics Announces Key Clinical & Corporate Updates โฆ
MONTREAL, Dec. 1, 2014 /CNW/ - Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) (Formerly Bioniche Life Sciences Inc. TST:BNC) today affirmed that they remain on track with โฆSee details»
Telesta Therapeutics Provides Strategic Update - PR Newswire
MONTREAL, Aug. 2, 2016 /PRNewswire/ - Telesta Therapeutics Inc. (TSX: TST)(PNK: BNHLF) Telesta Therapeutics today announced concrete actions and decisions stemming from its โฆSee details»
Telesta Therapeutics Publishes its Annual Consolidated Financial ...
Sep 14, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today issued its annual consolidated financial statements and associated Management's...See details»
Telesta Therapeutics, Inc. (Telesta Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Background: We have previously reported the results of a prospective multi-institutional study on the efficacy of MCNA in patients who recurred after intravesical BCG treatment [1]. Since that โฆSee details»
Telesta Therapeutics and Ipsen Announce Exclusive ... - Fierce โฆ
Oct 29, 2015 For more information, please visit www.telestatherapeutics.com. About Ipsen. Ipsen is a global specialty-driven biotechnological group with total sales exceeding โฌ1.2 billion โฆSee details»
Bioniche Life Sciences Inc. Rebrands as Telesta Therapeutics Inc.
BELLEVILLE, ON, Nov. 24, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC PNK: BNHLF) Bioniche Life Sciences today announced the accomplishment of another major โฆSee details»
Telesta Therapeutics Appoints Brian J. Groch as Chief ... - Newswire
Oct 8, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced the engagement of Brian J. Groch as Chief Commercial Officer, a new executive...See details»
Telesta Therapeutics Corporate Update - Newswire
Dec 14, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK:BNHLF) today provided an update on the Biologics License Application (BLA) for their drug MCNA1 that...See details»